Publications by authors named "Yoko Amada"

Claim this Profile
P
Pharmacokinetics of mirabegron, a β3-adrenoceptor agonist for treatment of overactive bladder, in healthy Japanese male subjects: results from single- and multiple-dose studies.
Hiromi Iitsuka, Tomoaki Tokuno, Yoko Amada, Hiroshi Matsushima, Masataka Katashima

Clin Drug Investig· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of YM928, a novel AMPA receptor antagonist, on seizures in EL mice and kainate-induced seizures in rats.
Hiroshi Yamashita, Kazushige Ohno, Yoko Amada, Hiroshi Inami, Jun-Ichi Shishikura

Naunyn Schmiedebergs Arch Pharmacol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of 2-[N-(4-chlorophenyl)-N-methylamino]-4H-pyrido[3.2-e]-1,3-thiazin-4-one (YM928), an orally active alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, in models of generalized epileptic seizure in mice and rats.
Hiroshi Yamashita, Kazushige Ohno, Yoko Amada, Hanae Hattori, Yukiko Ozawa-Funatsu

J Pharmacol Exp Ther· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional characterization of YM928, a novel moncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist.
Kazushige Ohno, Rie Tsutsumi, Naoyuki Matsumoto, Hiroshi Yamashita, Yoko Amada

J Pharmacol Exp Ther· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis